As new Covid-19 task force gets underway, threat looms of vaccine, monoclonal antibody-resistant variants

Jason Mast

Editor

Hours before President Biden’s Covid-19 team gave their first virtual press conference, the famed AIDS researcher David Ho delivered concerning news in a new …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

As new Covid-19 task force gets underway, threat looms of vaccine, monoclonal antibody-resistant variants

Jason Mast

Editor

Sign up to read this article for free.

Legend names a president of Carvykti; Novo Nordisk's top North America exec is stepping down

Athira gives up on lead Alzheimer’s drug, switches tack to ALS

Senior AstraZeneca exec detained in China amid wider investigation

Nkarta drops another cancer program as it leans into autoimmune disease

Soft RSV sales reveal a vaccine market failing to catch post-Covid momentum

Gene therapies don’t have to cost $4 million: New production platforms reduce development costs and risks

As new Covid-19 task force gets un­der­way, threat looms of vac­cine, mon­o­clon­al an­ti­body-re­sis­tant vari­ants

Jason Mast

Editor

Sign up to read this article for free.

Leg­end names a pres­i­dent of Carvyk­ti; No­vo Nordisk's top North Amer­i­ca ex­ec is step­ping down

Athi­ra gives up on lead Alzheimer’s drug, switch­es tack to ALS

Se­nior As­traZeneca ex­ec de­tained in Chi­na amid wider in­ves­ti­ga­tion

Nkar­ta drops an­oth­er can­cer pro­gram as it leans in­to au­toim­mune dis­ease

Soft RSV sales re­veal a vac­cine mar­ket fail­ing to catch post-Covid mo­men­tum

Gene ther­a­pies don’t have to cost $4 mil­lion: New pro­duc­tion plat­forms re­duce de­vel­op­ment costs and risks

As new Covid-19 task force gets underway, threat looms of vaccine, monoclonal antibody-resistant variants

Legend names a president of Carvykti; Novo Nordisk's top North America exec is stepping down

Athira gives up on lead Alzheimer’s drug, switches tack to ALS

Senior AstraZeneca exec detained in China amid wider investigation

Nkarta drops another cancer program as it leans into autoimmune disease

Soft RSV sales reveal a vaccine market failing to catch post-Covid momentum

Gene therapies don’t have to cost $4 million: New production platforms reduce development costs and risks